Interaction of single-chain urokinase with its receptor induces the appearance and disappearance of binding epitopes within the resultant complex for other cell surface proteins.

Binding of urokinase-type plasminogen activator (uPA) to its glycosylphosphatidylinositol-anchored receptor (uPAR) initiates signal transduction, adhesion, and migration in certain cell types. To determine whether some of these activities may be mediated by associations between the uPA/uPAR complex and other cell surface proteins, we studied the binding of complexes composed of recombinant, soluble uPA receptor (suPAR) and single chain uPA (scuPA) to a cell line (LM-TK- fibroblasts) that does not express glycosylphosphatidylinositol (GPI)-anchored proteins to eliminate potential competition by endogenous uPA receptors. scuPA induced the binding of suPAR to LM-TK- cells. Binding of labeled suPAR/scuPA was inhibited by unlabeled complex, but not by scuPA or suPAR added separately, indicating cellular binding sites had been formed that are not present in either component. Binding of the complex was inhibited by low molecular weight uPA (LMW-uPA) indicating exposure of an epitope found normally in the isolated B chain of two chain uPA (tcuPA), but hidden in soluble scuPA. Binding of LMW-uPA was independent of its catalytic site and was associated with retention of its enzymatic activity. Additional cell binding epitopes were generated within suPAR itself by the aminoterminal fragment of scuPA, which itself does not bind to LM-TK- cells. When scuPA bound to suPAR, a binding site for alpha 2-macroglobulin receptor/LDL receptor-related protein (alpha 2 MR/LRP) was lost, while binding sites for cell-associated vitronectin and thrombospondin were induced. In accord with this, the internalization and degradation of cell-associated tcuPA and tcuPA-PAI-1 complexes proceeded less efficiently in the presence of suPAR. Further, little degradation of suPAR was detected, suggesting that cell-bound complex dissociated during the initial stages of endocytosis. Thus, the interaction of scuPA with its receptor causes multiple functional changes within the complex including the dis-appearance of an epitope in scuPA involved in its clearance from the cell surface and the generation of novel epitopes that promote its binding to proteins involved in cell adhesion and signal transduction.

[1]  K. Preissner,et al.  The urokinase receptor is a major vitronectin-binding protein on endothelial cells. , 1996, Experimental cell research.

[2]  H. Petty,et al.  Urokinase-type plasminogen activator receptor reversibly dissociates from complement receptor type 3 (alpha M beta 2' CD11b/CD18) during neutrophil polarization. , 1996, Journal of immunology.

[3]  R. Pardi,et al.  alpha-2 Macroglobulin receptor/Ldl receptor-related protein(Lrp)- dependent internalization of the urokinase receptor , 1995, The Journal of cell biology.

[4]  J. Henkin,et al.  Enhancement of the Enzymatic Activity of Single-chain Urokinase Plasminogen Activator by Soluble Urokinase Receptor (*) , 1995, The Journal of Biological Chemistry.

[5]  T. L. Moser,et al.  Specific binding of urinary-type plasminogen activator (u-PA) to vitronectin and its role in mediating u-PA-dependent adhesion of U937 cells. , 1995, The Biochemical journal.

[6]  S. Rosenberg,et al.  Identification of the urokinase receptor as an adhesion receptor for vitronectin. , 1994, The Journal of biological chemistry.

[7]  S. Schultz-Cherry,et al.  The type 1 repeats of thrombospondin 1 activate latent transforming growth factor-beta. , 1994, The Journal of biological chemistry.

[8]  D. Lawrence,et al.  Regions involved in binding of urokinase-type-1 inhibitor complex and pro-urokinase to the endocytic alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein. Evidence that the urokinase receptor protects pro-urokinase against binding to the endocytic receptor. , 1994, The Journal of biological chemistry.

[9]  S. Waxman,et al.  Induction of cell migration by pro-urokinase binding to its receptor: possible mechanism for signal transduction in human epithelial cells , 1994, The Journal of cell biology.

[10]  D. Waltz,et al.  Reversible cellular adhesion to vitronectin linked to urokinase receptor occupancy. , 1994, The Journal of biological chemistry.

[11]  H. Petty,et al.  Physical association of complement receptor type 3 and urokinase-type plasminogen activator receptor in neutrophil membranes. , 1994, Journal of immunology.

[12]  W. Schleuning,et al.  Induction of c‐fos gene expression by urokinase‐type plasminogen activator in human ovarian cancer cells , 1994, FEBS letters.

[13]  M. Gyetko,et al.  The urokinase receptor is required for human monocyte chemotaxis in vitro. , 1994, The Journal of clinical investigation.

[14]  H. Li,et al.  Endocytosis of urokinase-plasminogen activator inhibitor type 1 complexes bound to a chimeric transmembrane urokinase receptor. , 1994, The Journal of biological chemistry.

[15]  N. Brünner,et al.  Confocal fluorescence microscopy of urokinase plasminogen activator receptor and cathepsin D in human MDA-MB-231 breast cancer cells migrating in reconstituted basement membrane. , 1994, Biotechnic & histochemistry : official publication of the Biological Stain Commission.

[16]  A. Copeta,et al.  Plasminogen activators as growth factorsof human fibroblasts , 1994 .

[17]  A. Mazar,et al.  Expression of urokinase receptors by human trophoblast. A histochemical and ultrastructural analysis. , 1994, Laboratory investigation; a journal of technical methods and pathology.

[18]  A. Mazar,et al.  Urokinase inhibits HL-60 cell proliferation in vitro. , 1994, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[19]  K. Danø,et al.  A novel, specific pro‐urokinase complex on monocyte‐like cells, detected by transglutaminase‐catalyzed cross‐linking , 1993, FEBS letters.

[20]  J. Henkin,et al.  Low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor mediates cellular uptake of pro-urokinase. , 1993, The Journal of biological chemistry.

[21]  A. Levinson,et al.  Prevention of metastasis by inhibition of the urokinase receptor. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[22]  W. Schleuning,et al.  Interaction of urokinase‐type plasminogenactivator (u‐PA) with its cellular receptor (u‐PAR) induces phosphorylation on tyrosine of a 38 kDa protein , 1993, FEBS letters.

[23]  D. Waltz,et al.  Cytokines induce urokinase-dependent adhesion of human myeloid cells. A regulatory role for plasminogen activator inhibitors. , 1993, The Journal of clinical investigation.

[24]  M. Ruggiero,et al.  Urokinase-urokinase receptor interaction: non-mitogenic signal transduction in human epidermal cells. , 1993, Biochemical and biophysical research communications.

[25]  R. Hammer,et al.  LDL receptor-related protein internalizes and degrades uPA-PAI-1 complexes and is essential for embryo implantation , 1992, Cell.

[26]  K. Skorstengaard,et al.  Disulfides modulate RGD-inhibitable cell adhesive activity of thrombospondin , 1992, The Journal of cell biology.

[27]  S. Moestrup,et al.  Purified alpha 2-macroglobulin receptor/LDL receptor-related protein binds urokinase.plasminogen activator inhibitor type-1 complex. Evidence that the alpha 2-macroglobulin receptor mediates cellular degradation of urokinase receptor-bound complexes. , 1992, The Journal of biological chemistry.

[28]  A. Mazar,et al.  Structural requirements for the growth factor activity of the amino-terminal domain of urokinase. , 1992, The Journal of biological chemistry.

[29]  D. Strickland,et al.  A novel mechanism for controlling the activity of alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein. Multiple regulatory sites for 39-kDa receptor-associated protein. , 1992, The Journal of biological chemistry.

[30]  D. Rifkin,et al.  Urokinase‐type plasminogen activator mediates basic fibroblast growth factor‐induced bovine endothelial cell migration independent of its proteolytic activity , 1992, Journal of cellular physiology.

[31]  A. Petros,et al.  Domain analysis of urokinase plasminogen activator (u-PA): Preparation and characterization of intact A-chain molecules , 1992 .

[32]  B. Schwartz,et al.  Single chain urokinase. Augmentation of enzymatic activity upon binding to monocytes. , 1991, The Journal of biological chemistry.

[33]  H. Chapman,et al.  An autocrine role for urokinase in phorbol ester-mediated differentiation of myeloid cell lines. , 1991, The Journal of clinical investigation.

[34]  F. Blasi,et al.  Cellular receptor for urokinase plasminogen activator. Carboxyl-terminal processing and membrane anchoring by glycosyl-phosphatidylinositol. , 1991, The Journal of biological chemistry.

[35]  L. Orci,et al.  The receptor for urokinase type plasminogen activator polarizes expression of the protease to the leading edge of migrating monocytes and promotes degradation of enzyme inhibitor complexes , 1990, The Journal of cell biology.

[36]  R. Silverstein,et al.  Thrombospondin forms complexes with single-chain and two-chain forms of urokinase. , 1990, The Journal of biological chemistry.

[37]  L. Magnelli,et al.  Interaction of urokinase A chain with the receptor of human keratinocytes stimulates release of urokinase-like plasminogen activator. , 1990, Experimental cell research.

[38]  L. Rosenfeld,et al.  Interaction of single-chain urokinase-type plasminogen activator with human endothelial cells. , 1990, The Journal of biological chemistry.

[39]  M. Scully,et al.  Plasminogen activation initiated by single-chain urokinase-type plasminogen activator. Potentiation by U937 monocytes. , 1989, The Journal of biological chemistry.

[40]  J. Kreisberg,et al.  Urokinase-dependent adhesion loss and shape change after cyclic adenosine monophosphate elevation in cultured rat mesangial cells. , 1988, The Journal of clinical investigation.

[41]  L. Magnelli,et al.  Interaction of urokinase with specific receptors stimulates mobilization of bovine adrenal capillary endothelial cells. , 1988, Experimental cell research.

[42]  R. Hynes,et al.  Cell attachment to thrombospondin: the role of ARG-GLY-ASP, calcium, and integrin receptors , 1988, The Journal of cell biology.

[43]  D. Mosher,et al.  Conformational change in thrombospondin induced by removal of bound Ca2+ A spin label approach , 1988, FEBS letters.

[44]  A. Vaheri,et al.  Ultrastructural localization of plasma membrane-associated urokinase- type plasminogen activator at focal contacts , 1988, The Journal of cell biology.

[45]  A. Gee,et al.  Urokinase: a chemotactic factor for polymorphonuclear leukocytes in vivo. , 1987, Journal of immunology.

[46]  G. Dini,et al.  Interaction of urokinase with specific receptors abolishes the time of commitment to terminal differentiation of murine erythroleukaemia (Friend) cells , 1987, British journal of haematology.

[47]  E. Appella,et al.  The receptor-binding sequence of urokinase. A biological function for the growth-factor module of proteases. , 1987, The Journal of biological chemistry.

[48]  E. Appella,et al.  The Receptor-Binding Sequence of Urokinase , 1987 .

[49]  K. Fujikawa,et al.  The activation of pro-urokinase by plasma kallikrein and its inactivation by thrombin. , 1986, The Journal of biological chemistry.

[50]  V. Dixit,et al.  Monoclonal antibodies that recognize calcium-dependent structures of human thrombospondin. Characterization and mapping of their epitopes. , 1986, The Journal of biological chemistry.

[51]  K. Preissner,et al.  Physicochemical characterization of human S-protein and its function in the blood coagulation system. , 1985, The Biochemical journal.

[52]  T. Suyama,et al.  Proteolytic cleavage of single-chain pro-urokinase induces conformational change which follows activation of the zymogen and reduction of its high affinity for fibrin. , 1985, The Journal of biological chemistry.

[53]  J. Connolly,et al.  The structure of human platelet thrombospondin. , 1985, The Journal of biological chemistry.

[54]  K. Danø,et al.  Plasminogen activators, tissue degradation, and cancer. , 1985, Advances in cancer research.

[55]  J. Lawler,et al.  Cooperative binding of calcium to thrombospondin. The effect of calcium on the circular dichroism and limited tryptic digestion of thrombospondin. , 1983, The Journal of biological chemistry.